Cumberland Advisors Inc Merck & Co., Inc. Transaction History

Cumberland Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$73.51 - $82.4 $263,533 - $295,404	-3,585 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$70.31 - $77.77 $210,930 - $233,310	-3,000 Reduced 45.56%	3,585 $279,000
Q4 2020 Jan 20, 2021	BUY	$71.77 - $79.65 $157,894 - $175,230	2,200 Added 50.17%	6,585 $539,000
Q2 2019 Jul 11, 2019	SELL	$69.84 - $81.59 $6,984 - $8,159	-100 Reduced 2.23%	4,385 $368,000
Q4 2018 Jan 08, 2019	BUY	$65.24 - $75.71 $292,601 - $339,559	4,485 New	4,485 $343,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Cumberland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Cumberland Advisors Inc with notifications on news.